Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Cash & Equivalents (2021 - 2025)

Tenon Medical (TNON) has 5 years of Cash & Equivalents data on record, last reported at $3.4 million in Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 62.43% year-over-year to $3.4 million; the TTM value through Sep 2025 reached $3.4 million, down 62.43%, while the annual FY2024 figure was $6.5 million, 169.15% up from the prior year.
  • Cash & Equivalents reached $3.4 million in Q3 2025 per TNON's latest filing, down from $7.8 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $10.3 million in Q1 2025 and bottomed at $2.0 million in Q2 2024.
  • Average Cash & Equivalents over 5 years is $4.9 million, with a median of $3.9 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: tumbled 66.37% in 2024, then soared 298.68% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $2.3 million in 2021, then decreased by 7.48% to $2.1 million in 2022, then rose by 14.04% to $2.4 million in 2023, then skyrocketed by 169.15% to $6.5 million in 2024, then tumbled by 47.33% to $3.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $3.4 million in Q3 2025, $7.8 million in Q2 2025, and $10.3 million in Q1 2025.